Alfresa Holdings (TSE:2784) Moat Score: 6/10 (As of Jul. 29, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:2784 Alfresa Holdings Corp TSE:2784
83 GF Score
Price 円2,457.50
GF Value 円2,542.44
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Alfresa Holdings Moat Score?

Alfresa Holdings TSE:2784 +0.21% 83 Moat Score is 6 as of Jul. 29, 2026. GuruFocus rates TSE:2784 with a GF Score™ of 83/100 and a GF Value™ of 円2,542.44 (Fairly Valued). The stock has 1 warning sign investors should review. Among 121 Medical Distribution companies, Alfresa Holdings ranks better than 97.52% on this metric.

Alfresa Holdings has the Moat Score of 6, which implies that the company might have Narrow Moat - Strong narrow moat, clearly distinguishable but not wide.

Alfresa Holdings has Narrow Moat: Alfresa Holdings has a strong narrow moat due to its robust distribution network in the pharmaceutical sector and significant regulatory barriers in Japan. However, it faces competition and lacks global brand strength, preventing a wide moat classification.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Alfresa Holdings might have Narrow Moat - Strong narrow moat, clearly distinguishable but not wide.

Alfresa Holdings  (TSE:2784) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Alfresa Holdings Moat Score Related Terms

TSE:2784 vs MCK, COR, CAH: Moat Score Comparison

For the Medical Distribution subindustry, Alfresa Holdings's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alfresa Holdings Moat Score vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Alfresa Holdings's Moat Score distribution charts can be found below:

* The bar in red indicates where Alfresa Holdings's Moat Score falls into.


TSE:2784
83GF Score
Alfresa Holdings Corp TSE:2784
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 6 mean?
Alfresa Holdings (TSE:2784) has a Moat Score of 6 as of Jul. 29, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Alfresa Holdings ranks #3 out of 121 companies in the Medical Distribution industry, placing it in the top 2.5%.
Is Alfresa Holdings' Moat Score too high?
Alfresa Holdings' current Moat Score is 6. Based on the distribution chart, Alfresa Holdings ranks #3 out of 121 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Alfresa Holdings has a GF Score™ of 83/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Alfresa Holdings' Moat Score compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Alfresa Holdings ranks #3 out of 121 companies for Moat Score. This places Alfresa Holdings in the top 3% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Medical Distribution company?
A good Moat Score depends on the Medical Distribution industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Alfresa Holdings's current Moat Score is 6. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alfresa Holdings stock overvalued right now?
Based on GuruFocus' analysis, Alfresa Holdings (TSE:2784) is currently considered Fairly Valued. The stock's GF Value™ is 円2,542.44, compared to a current price of 円2,457.50 — trading 3.3% below its estimated fair value. The current Moat Score is 6. Alfresa Holdings' overall GF Score™ is 83/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Alfresa Holdings (TSE:2784), the current Moat Score is 6 as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alfresa Holdings (TSE:2784) Overvalued in 2026?

Based on GuruFocus' analysis, Alfresa Holdings stock appears to be undervalued. The current stock price of 円2,457.50 is trading 3.3% below its estimated GF Value™ of 円2,542.44. GuruFocus considers Alfresa Holdings to be Fairly Valued.

Key valuation signals for TSE:2784:

  • Moat Score: 6
  • GF Value™: 円2,542.44 vs. price of 円2,457.50 (3.3% below fair value)
  • GF Score™: 83/100 with 1 warning sign

No single metric tells the full story. See the TSE:2784 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Alfresa Holdings Business Description

Other Exchanges ALFRY:USA
Address 1-1-3 Otemachi, Chiyoda-ku, Tokyo, JPN, 100-0004
Alfresa Holdings Corp is engaged in the pharmaceutical distribution and related businesses. The company operates through four reportable segments: Wholesale business of medical drugs, Self-Medication Wholesale Business, Pharmaceutical Manufacturing Business, and Medical-Related Business. Its operations include the wholesale of ethical and over-the-counter pharmaceuticals, the manufacture and sale of pharmaceuticals, medical testing reagents, and medical equipment, as well as the operation of dispensing pharmacies.
83GF Score

Get the complete analysis for TSE:2784

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円2,457.50
Price
円2,542.44
GF Value